These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15214329)

  • 1. Novelty: new products and processes.
    French H
    Nat Rev Drug Discov; 2004 Jun; 3(6):469. PubMed ID: 15214329
    [No Abstract]   [Full Text] [Related]  

  • 2. US switch to first-to-file patents could cause minor shake-up.
    Waters H
    Nat Med; 2011 Aug; 17(8):906-7. PubMed ID: 21818070
    [No Abstract]   [Full Text] [Related]  

  • 3. Sales from licensed and acquired products to increase by 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704
    [No Abstract]   [Full Text] [Related]  

  • 4. Protecting the balance of Hatch-Waxman: understanding the industry's new dynamics for the 21st century.
    Schroeder RG; Papas P
    Food Drug Law J; 2001; 56(1):19-26. PubMed ID: 11942348
    [No Abstract]   [Full Text] [Related]  

  • 5. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 6. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 7. Added matter and patentability.
    Soames C
    Nat Rev Drug Discov; 2005 Jul; 4(7):531. PubMed ID: 16075484
    [No Abstract]   [Full Text] [Related]  

  • 8. New rules for natural products research.
    Gollin MA
    Nat Biotechnol; 1999 Sep; 17(9):921-2. PubMed ID: 10471938
    [No Abstract]   [Full Text] [Related]  

  • 9. What shoulder and what art.
    Nat Rev Drug Discov; 2005 Dec; 4(12):943. PubMed ID: 16370069
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV drugs. New Congress could create hurdles for drug patents.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17319014
    [No Abstract]   [Full Text] [Related]  

  • 11. Are rich nations up for drug reform?
    Check E
    Nature; 2006 May; 441(7090):135. PubMed ID: 16688137
    [No Abstract]   [Full Text] [Related]  

  • 12. The patentability of antibodies in the United States.
    Lu DL; Collison AM; Kowalski TJ
    Nat Biotechnol; 2005 Sep; 23(9):1079-80. PubMed ID: 16151395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent watch: one valid claim is all that is needed.
    Harrison C
    Nat Rev Drug Discov; 2013 Jun; 12(6):416-7. PubMed ID: 23722337
    [No Abstract]   [Full Text] [Related]  

  • 14. Can business and science coexist in this century?
    Ackerman W
    J Ark Med Soc; 2001 Jun; 97(12):401. PubMed ID: 11383496
    [No Abstract]   [Full Text] [Related]  

  • 15. European Union joins fight over drug patents.
    Watson R
    BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440933
    [No Abstract]   [Full Text] [Related]  

  • 16. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 17. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of India's new patents law 2005: a physician's perspective.
    Lele RD
    J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.